Clinical Trials and Lung Cancer Biomarkers

Justin F. Gainor, M.D., explains when a clinical trial might be right for patients with lung cancer mutations in this clip from our expert panel discussion on tumor testing.

Video Transcript

When is a clinical trial right for someone that has a lung cancer mutation?

A lot of people have strong feelings when they hear clinical trial, thinking 'oh, it's just because I've exhausted other options,' and I want to emphasize that is not the case. If someone has one of these genetic changes that is actionable, where we know a lot about it, but it’s not approved yet, I would argue that for those people, depending on what the target is, sometimes a clinical trial may be the most appropriate very first therapy.

For more information and to see the full recorded discussion, visit

Generously supported by AstraZeneca, Bristol-Myers Squibb, Foundation Medicine, Pfizer, and Merck & Co., Inc.

Page last updated: March 22, 2020

, | Jun 24, 2021